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Abstract
Background: Whole body vibration (WBV) is a novel modality of exercise shown to improve musculoskeletal
function. This study aims to examine the effects of standing posture during low magnitude WBV training on
muscle function and muscle morphology in older adults.
Methods: Nineteen men and women (50-80 years) were recruited to a three month randomised controlled trial
and allocated to one of three groups: WBV with flexed knees (FK), WBV with locked knees (LK), or sham WBV with
flexed knees (CON). Exposure was intermittent (1 min WBV:1 min rest) for 20 min, three times per week for 13
weeks. Measurements were taken at baseline and at three months. Primary outcomes included upper and lower
body muscle function (strength, power and velocity). Secondary outcomes were muscle morphology, balance,
habitual and maximal gait velocity, stair climb power, and chair stand performance.
Results: Sixteen subjects completed the study. Relative (%) upper body contraction velocity improved significantly
after WBV with FK compared to LK (FK 16.0%, LK -7.6%, CON 4.7, p = 0.01). Relative upper body strength (LK 15.1%,
p = 0.02; FK 12.1%, p = 0.04; CON 4.7%) increased significantly following WBV compared to control. Absolute (p =
0.05) and relative (p = 0.03) lower leg strength significantly improved with both standing postures (LK 14.4%; FK
10.7%; CON 1.3%). Only the LK group differed significantly from CON in relative leg strength gains (p = 0.02).
Potentially clinically meaningful but statistically non-significant improvements in lower leg muscle cross-sectional
area (LK 3.7 cm
2, FK 2.4 cm
2, CON 2.2 cm
2 p = 0.13) were observed after WBV with LK compared to the other
groups. No significant effects of WBV on any functional performance tests were observed.
Conclusions: Our results suggest that WBV may improve muscle strength and contraction velocity in some muscle
groups in older adults. However, hypothesised differential adaptation to standing posture (FK > LK) was observed
only for upper body contraction velocity, making recommendations regarding this prescriptive element
inconclusive. The efficacy, mechanism of action and long term feasibility of WBV for musculoskeletal health in older
adults warrants continued investigation in robustly designed, sufficiently powered future studies.
Trial Registration: ACTRN12609000353291.
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Age-related loses of skeletal muscle mass (sarcopenia)
[1,2] and altered neuromuscular activation manifest as
changes in muscle function in older adults [3,4]. Muscle
weakness, reduced muscle power and slower contraction
velocity are amongst these functional changes [5-9] and
are important and prevalent risk factors for falls, frailty,
disability and loss of functional independence in the
aged [9-12]. Sarcopenia is common, being reported to
occur in 40% of people aged 80 years and older [13],
highlighting the risk of disability and loss of indepen-
dence in this cohort.
Presently, pharmacological treatment [14-19], and
resistance exercise [20,21] are available to alleviate age-
related muscular deterioration [22]. However pharmaco-
logical methods have been variably successful, often
resulting in unwanted side-effects [22,23]. Resistance
training has been shown to be an effective method to
counteract sarcopenia [21]; though for some older indi-
viduals with very advanced frailty or certain diseases,
robust resistance exercise may be unavailable or pre-
cluded [5,24]. Whole Body Vibration (WBV) exposure
has therefore been proposed as a potentially safe, low-
intensity alternative to current modalities to combat sar-
copenia in exercise-intolerant, exercise-aversive or mobi-
lity-limited individuals, without the potential risks or
behavioural barriers associated with high intensity
exercise.
WBV uses high-frequency mechanical stimuli gener-
ated by a vibrating platform which are transmitted
through the body [25]. The mechanical stimuli produced
are thought to use neural pathways, stimulating muscle
spindles, the sensory receptors located within the belly
o ft h em u s c l e .T h e1 aa f f e r e n ts i g n a l sa r et r a n s m i t t e d
monosynaptically to activate alpha-motoneurons, initiat-
ing muscle fibre contractions [26,27]. The vibration sti-
mulus is thought to result in a tonic vibration reflex, or
tonic contraction of the muscle [28].
Improvements from WBV exercise have been reported
in muscle function (strength [2,29-33], power [2,32],
velocity [32]), balance [29,34-37], a reduction of muscle
spasticity in those with cerebral palsy [38], and postural
control in those with Parkinson’s Disease [39]. However,
many studies have included resistance training with
non-uniform resistance protocols between WBV and
non-WBV groups [25,26,40,41], leaving the mechanism
of improvements unclear. Few studies [32,42] have
examined the effect of WBV alone (without concomitant
exercise on the platform), and some trials [1,42] have
reported non-significant musculoskeletal adaptations.
Furthermore, the ideal vibration dose, time course, fre-
quency and posture to elicit an optimal response remain
uncertain.
Although the posture adopted during WBV exercise
has been observed to significantly influence the trans-
mission of vibration to the skeleton [2,32,43], no studies
have specifically investigated posture and its influence
on adaptation to WBV. Vibration has been observed as
best transmitted up the skeleton when standing with a
straight, erect posture [44]. Using transcutaneous pins
in the spine and femur, Rubin et al [44] reported a
higher transmissibility of vibration through the skeleton
when participants stood with locked knees, compared to
a relaxed or flexed knee posture. Performing static exer-
cise concomitant with flexed knee condition during
WBV training has been shown to significantly increase
activation of leg muscles [45,46]. Significant improve-
ments in muscle strength and power after WBV expo-
sure have been reported when subjects stood with knees
slightly flexed [2,32]. Russo et al [32] found a significant
increase in leg muscle power and velocity of contraction,
and Rees et al [2] reported increases in both ankle plan-
tar-flexion torque and power when comparing WBV to
a control group. Together these results suggest that
knee flexion may facilitate muscle improvements during
WBV exposure.
However, to our knowledge, no studies have directly
examined the effect of knee posture adopted during
WBV on muscle adaptations. Robust, well-designed stu-
dies, particularly in older adults at risk of sarcopenia,
are required in order to determine the most effective
vibration prescription to elicit muscle adaptations. The
literature suggests that a single WBV dose may be dif-
ferently transmitted to muscle tissue dependent on knee
position. Therefore the aim of this study was to deter-
mine the effect of knee position adopted during WBV
on adaptation to the vibration stimulus in muscle in
older adults, in order to refine the WBV prescription for
these important outcomes. Specifically, we hypothesised
that: (1) WBV exposure would improve all outcomes
relative to Control and (2) WBV exposure with flexed
knees would dampen skeletal vibration transmission by
absorbing energy into muscles, thereby enhancing mus-
cle activation, contractile activity and adaptations.
Methods
Study Design
The study was a three-month double blind, randomised
placebo-controlled clinical trial to investigate the effect
of knee position during WBV exposure on muscle func-
tion, muscle morphology and physical performance in
older adults. Outcome measures were assessed at base-
line and three months. The primary analytic strategy
was complete case analysis, without regard to interven-
tion adherence, and without imputation for missing
data.
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Participants were randomised to one of three groups fol-
lowing the completion of baseline assessments by an
investigator independent of the study via a computerised
program [47] using the method of randomly permuted
blocks. Strata used included gender, age and use of
osteoporosis medication, and randomisation was per-
formed in blocks of six. Allocation concealment was
complete, as participants were notified of their group
assignment via a sealed, opaque envelope distributed
after the completion of all baseline assessments.
Participants
Participants were recruited by means of posters and arti-
cles in local medical, physiotherapy and dental practices,
pharmacies, community businesses, Senior citizens,
Bowling and Returned Soldiers’ Leagues Clubs, senior
websites, online forums, newsletters, newspapers, and
via letterbox drops to houses. Recruitment occurred
during March to June 2009.
Participant screening was conducted using a telephone
questionnaire. Inclusion criteria were non-institutiona-
lised adults aged 50 and older (women at least one year
postmenopausal), no cognitive impairment, able to stand
unaided for at least 20 minutes, perform a partial squat
for 60 seconds, and be willing to participate in the
study. If currently on medications for osteoporosis (e.g.
bisphosphonates, Vitamin D, calcium), dosages had to
be maintained for the duration of the study. Exclusion
criteria included: contraindications to vibration exposure
(pacemaker, current kidney or gall stones, acute lower
back pain, blood clot or thrombosis within the last six
months, fracture or joint replacement within the past 12
months, vibration-related injuries, amputation of lower
extremities other than toes, Raynaud’s disease), contra-
indications to strength testing, active malignancy or a
terminal or rapidly progressive illness, and diseases
related to bone metabolism other than osteoporosis,
such as Paget’s disease, end-stage renal failure, rheuma-
toid arthritis or multiple myeloma.
Written informed consent was obtained from all partici-
pants prior to enrolment. The study was approved by the
University of Sydney Human Research Ethics Committee
and registered under the Australia New Zealand Clinical
Trials Registry (Number: ACTRN12609000353291).
Intervention
Whole Body Vibration Exposure
Participants were assigned to one of three groups (two
experimental intervention groups and one sham group)
for a three-month period. The WBV dose and posture
paradigms are described in Table 1. WBV exposure for
all groups was intermittent (1 min vibration:1 min rest)
for 20 min, 3 days per week for 3 months (13 weeks).
The total number of exercise sessions was 39. WBV was
conducted standing position on a synchronous vibration
platform engineered by Australian Catholic University
(2004). The motor speed controller was calibrated to
v i b r a t ea taf r e q u e n c yo f1 2H z .T h i sf r e q u e n c ys e t t i n g
was achieved by attaching a spring-loaded potentiometer
underneath the platform base and measuring the vibra-
tion rate. The amplitude of the vibration (1 mm peak to
peak) was determined by the size of the cam fitted to
the motor shaft. All participants stood on the vibration
platform with their feet shoulder-width apart, hands by
their sides, and wore standardised thick cotton socks to
prevent any dampening that might result from footwear
[48].
We recognise that a four group, fully-factorial design
would have been optimal to test the main effects of
vibration and knee position, and the interaction of vibra-
tion and knee position on study outcomes. However,
due to the pilot nature of the study, we chose three
groups that would allow us to separate the effects of
attention, vibration and standing posture and investigate
two primary questions: (1) What is the effect of WBV
exposure added to a constant knee position/exposure
volume (Control/Flexed (CON) vs. Vibration/Flexed
(FK))? and (2) What is the effect of knee flexion on a
constant WBV exposure volume (Vibration/Locked (LK)
Table 1 Whole Body Vibration Groups and Protocols
Whole Body Vibration
Group
Vibration Posture on Platform Vibration Dose
Frequency
(Hz)
Peak-to-Peak Displacement
(mm)
Magnitude (Peak
Acceleration) (g)
FK Active Flexed Knees
(20°flexion)
12 1 0.3
LK Active Locked knees 12 1 0.3
CON Sham
Control
Flexed knees
(20°flexion)
12 0 0
FK: Flexed Knees Group
LK: Locked Knees Group
CON: Control Group
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LK group was not of primary interest, as we recognised
it would not be possible to isolate the effects of the two
experimental condition changes (knee position and
vibration exposure) from the control condition.
Each session was supervised by two trained research
assistants in a University gymnasium. All participants
were blinded as to which groups were hypothesised to be
sham or active. Trainers by necessity were not blinded.
The groups trained at separate times, to avoid unblinding
and contamination. During CON training, the platform
emitted a noise as the motor vibrated at a frequency of
12 Hz. However the amplitude was set to 0 mm, giving 0
g magnitude and providing a true sham control. During
the FK conditions, a plastic sheet with the desired knee
angle (20°) marked was taped to each participant’s knee.
During the LK condition, participants were instructed to
lock knees but not to perform an isometric quadriceps
contraction during the vibration exposure. The standing
postures are depicted in Figure 1.
Attendance and completion of the exposure dose was
monitored by the instructor at each session. Partici-
pants were permitted an additional four weeks to make
up any missed sessions to reach their target 39
sessions.
Outcomes
All outcomes were collected in double-blind fashion
(both participants and assessors blinded). Baseline
assessments were blinded (collected pre-randomisation)
and measured by two assessors who also supervised the
training sessions. Assessments at three months were
measured by a different assessor blinded to the partici-
pants’ group allocation and otherwise uninvolved in
study procedures.
Primary Outcomes
Muscle Function (Strength, Power and Velocity) Mus-
cle function was assessed using Keiser pneumatic-resis-
tance training equipment (Keiser Sports Health
E q u i p m e n t ,I n c . ,F r e s n o ,C A ) .S t r e n g t hw a sm e a s u r e d
using one repetition maximum (1RM) in two bilateral
exercises: chest press and horizontal leg press. A 1RM
was defined as the maximum load that can be lifted
once while maintaining correct technique and reaching
a full range of motion. Power and velocity were mea-
sured at 20, 30, 40, 50, 60, 70, 80, 90, and 100% of
Figure 1 Standing position on vibration platform. (a) Flexed knees with marker, the standing position for the FK (flexed knee) and CON
(Control) groups during the vibration or sham stimulus respectively, and (b) Locked knees, the standing position for the LK (locked kness) group
during the vibration stimulus.
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maximal explosive efforts were performed with 30-60
seconds rest in between [49].
Secondary Outcomes
Muscle Morphology Total and regional (arms, legs and
trunk) skeletal muscle mass and fat mass. Muscle-cross
sectional area of mid-calf and mid-forearm were mea-
sured by Peripheral Quantitative Computed Tomogra-
phy (pQCT) (Stratec XCT 2000; Medizintechnik,
Pforzheim, Germany). The precision of repeat pQCT
measurements was 0.7-1.4% (radius) and 0.8-2.9% (tibia)
after repositioning in eight adults.
Physical Performance Tests of physical performance
included maximal (CV = 2.09%) and habitual (CV =
3.16%) gait speed over two meters, stair climb power,
chair stand and six minute walk distance (CV = 5%)
[50]. Balance, measured by balance index [49] was
assessed on a computerised force platform (Chattecx
Dynamic Balance System, Chattecx Corp, Chatanooga
G r o u pI n c ,H i x s o n ,T N ;S o f t w a r ev e r s i o n4 . 2 0 ) .T h e
mean of duplicate habitual gait velocity and maximum
of duplicate maximal gait velocity and stair climb power
measures were used. The remainder of the tests (bal-
ance, six minute walk, chair stand) were assessed only
once at each time point.
Covariates
Anthropometrics
Height (cm) was measured using a wall-mounted stadi-
ometer (Holtain stadiometer; Holtain Limited, Crym-
mych Pembs, UK), and body mass (kg) was measured
using an electronic scale (HW-100k, A&D Bench Scales,
Bradford, MA). These were measured in triplicate and
the mean value used to calculate body mass index
(BMI) (kg/m
2). The CV of triplicate measurement on
t h es a m ed a yi nt h ew h o l es a m p l ew a s0 . 1 4 %f o rh e i g h t
and 0.04% for body mass.
Demographics and Health Questionnaires
Demographic characteristics and self-reported medica-
tions and health conditions were assessed using a ques-
tionnaire. Habitual physical activity level was estimated
by the Physical Activity Scale for the Elderly (PASE)
[51]. All questions covered a seven-day period prior to
completing the questionnaire, using results to compare
physical activity reported between the two time points.
A weekly questionnaire was conducted to monitor
health status and possible adverse effects of vibration
exposure. These were defined ap r i o r iby review of
existing literature, and included questions probing
details of illnesses, symptoms or injuries subjects may
have experienced in the past week, changes in medica-
tions, visits to health care professionals, any changes in
their physical, mental or emotional health and reasons
for any missed exercise sessions.
Statistical Analysis
Statistical analyses were performed using SPSS for Win-
dows (Version 17.0). Data distributions were inspected
visually and statistically for normality. Normally distrib-
uted data were reported as mean ± standard deviation
(SD). Non-normally distributed data were normalised
via log transformation, and if not possible, non-para-
metric statistics were used for these variables. Post hoc
power analysis was calculated using the statistical pro-
gram G Power (version 3.1.0) [52].
The primary analytic strategy compared the differ-
ences in primary and secondary outcomes between the
locked knees, unlocked knees and sham WBV groups
using all available data regardless of intervention com-
pliance level. Analysis of covariance (ANCOVA) models
of absolute change scores were constructed to compare
t h eg r o u p su s i n gt h ec h a n g es c o r ea st h ed e p e n d e n t
variable and the baseline score as a covariate. Additional
covariates considered for inclusion were characteristics
that were different between the groups at baseline and
related to the variable of interest (potential confoun-
ders). For muscle performance and body composition
outcomes the month of each subject’s baseline assess-
ment was used as an additional covariate to control for
the natural fluctuation of these parameters with chan-
ging seasons [53]. Fisher’s post hoc Least Significant Dif-
ference (LSD) t tests were used for all pairwise
comparisons whenever the f ratio in ANCOVA models
was significant (P ≤ 0.05), to ascertain which groups
were different from each other. Hedge’s bias-corrected
relative effect sizes (ES) and 95% confidence intervals
were calculated for selected outcomes by COE’s calcula-
tor [54] as:
Change in Treatment Group - Change in Control
Group/pooled baseline SD A p-value of ≤0.05 and/or
95% CI exclusive of zero were accepted as statistically
significant. Cohen’s definition of effect size was used
(Negligible = 0.2; Low = 0.2 - 0.49; Moderate = 0.5 -
0.79; Large = 0.8+) [55].
Results
Recruitment
From 154 persons assessed for eligibility, 19 were
recruited and enrolled into the study (Figure 2). Two
participants withdrew from the study (one after 14
weeks and the other following three sessions of expo-
sure) due to personal reasons (LK = 1, CON = 1). One
participant had not completed three months of exposure
b yt h et i m eo ft h i sa n a l y s i s( F K=1 )a n dw a sn o t
included in this report.
Participant Characteristics
The mean age of participants was 64.4 ± 8.1 (range 50-
80) years. Participants were generally healthy but
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Page 5 of 13Potential Subjects
(n=154) Excluded (n=82)
Reasons:
Not meeting inclusion criteria (n=0)
Cannot Commit (n=54)
No Longer Interested (n=18)
Medical (n=10)
Analysed (n= 5)
Excluded from analysis (n= 1)
Intervention Incomplete
n=6
Lost to follow-up (n= 0)
Discontinued intervention (n=0)
FK Group
Allocated to intervention (n=6)
Received allocated intervention 
(n=6)
n=7
Lost to follow-up and 
discontinued intervention (n=1)
Could not commit
Control
Allocated to intervention (n= 8)
Received allocated intervention 
(n=8)
Analysed (n= 7)
Excluded from analysis (n= 0)
Intervention Incomplete
Analysis
Follow-Up
Randomized (n=19)
Telephone Screened
Screened (n=72)
LK Group
Allocated to intervention (n= 5)
Received allocated intervention 
(n=5)
n=4
Lost to follow-up and 
discontinued intervention (n=1)
Could not commit
Analysed (n= 4)
Excluded from analysis (n=0)
Intervention Incomplete
Excluded (n=53)
Reasons:
Can’t Commit (n=15)
Not Interested (n=35)
Medical (n=3)
Allocation
Figure 2 Participant flow through the trial.
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Page 6 of 13overweight with an average of 2.2 co-morbidities, most
commonly osteoarthritis (63%), hypertension (47%) and
lower back pain (47%) (Table 2). At baseline, no signifi-
cant or clinically important differences were found
between groups for any characteristics (Tables 2 and 3).
Compliance/Adverse Effects
No adverse events attributable to WBV exposure were
reported. Compliance (number of vibration sessions
completed divided by the 39 possible sessions available
to each participant) for those completing the three
months of WBV exposure was 98.8% with participants
t a k i n g ,o na v e r a g e ,4 2d a y so v e r1 3 - 1 7w e e k st oc o m -
plete the 39 planned sessions.
Outcomes
Participants’ baseline body composition, muscle func-
tion, and physical performance are presented in Tables
2 and 3. Between group comparisons of change scores
are presented in Table 4.
Primary Outcomes
As hypothesised, relative (%) upper body (chest press)
peak contraction velocity significantly improved after
WBV exposure in the FK group compared to LK (CON
4.7%; FK 16.0% vs. LK - 7.6%, p = 0.01) (Figure 3), and
similar trends were observed for changes in absolute
u p p e rb o d yv e l o c i t y( T a b l e4 ) .T h i sw a ss u p p o r t e db ya
large effect size (ES) (ES = 0.82, 95% Confidence Inter-
vals (CI) (-0.87, 2.52)). Relative (p = 0.03) and absolute
(p = 0.05) lower leg (leg press) strength (Figure 4)
increased significantly with both standing postures dur-
ing WBV exposure, (LK 14.4%; FK 10.7%; CON 1.3%;
ES 0.12, 95% CI (-1.15, 1.39)), however, unexpectedly
more so with LK than FK. Furthermore, only the LK
group was significantly different from CON in relative
strength gains (p = 0.02). Similarly, relative upper body
strength improved significantly following WBV com-
pared to the control group (LK 15.1%, p = 0.02; FK
12.1%, p = 0.04; CON 4.7%; ES 0.05, 95% CI (-1.34,
1.43)) (Figure 5), however, contrary to our hypothesis,
greater improvements were observed with LK than with
FK. No significant changes were observed in peak mus-
cle power in any group (Table 4).
Secondary Outcomes
Potentially clinically meaningful but statistically non-sig-
nificant improvements in lower leg muscle cross-
Table 2 Baseline Participant Characteristics
Variable Total (n = 19) FK (n = 6) LK (n = 5) CON (n = 8) p-value*
Age (years) 64.4 ± 8.1 63.3 ± 7.6 69.0 ± 6.9 62.3 ± 8.8 0.34
8/11 4/2 3/2 4/4
Gender M/F, (%Female) 0.47
(58%) (69%) (60%) (50%)
Height (cm) 166.7 ± 9.5 166.7 ± 9.1 164.1 ± 6.1 168.4 ± 12.0 0.76
Body Mass (kg) 79.5 ± 15.8 72.9 ± 10.4 81.1 ± 9.7 83.4 ± 121.2 0.48
Body Mass Index (kg/m
2)
a 28.5 ± 4.3 26.2 ± 2.8 30.0 ± 2.3 29.2 ± 5.7 0.30
Co morbidities/conditions, n (%)
- Osteoarthritis 12 (63.2) 4 3 5 0.97
- Hypertension 9 (47.4) 1 3 5 0.19
- Chronic Lower Back Pain 9 (47.4) 2 2 5 0.52
- Osteoporosis 5 (26.3) 1 1 3 0.64
Total Co morbidities (#) 2.2 ± 1.2 1.3 ± 1.2 2.6 ± 1.1 2.5 ± 1.1 0.13
Total Medications/day (#) 4 ± 3.9 4.5 ± 4.1 3 ± 1.2 4.4 ± 5.3 0.81
Habitual Physical Activity Level
b 146.1 ± 44.1 137.3 ± 60.0 160.0 ± 49.9 145.8 ± 30.0 0.75
Skeletal Muscle Cross Sectional Area (mm
2)
c
- Mid-Calf 67.8 ± 15.1 59.5 ± 12.9 72.6 ± 12.1 71.4 ± 17.6 0.27
- Mid-Forearm 33.5 ± 11.0 30.5 ± 11.3 35.0 ± 11.1 35.1 ± 11.8 0.728
All data presented as mean ± SD
Continuous variables analysed by ANOVA for normally distributed data
Categorical variables analysed by Chi square test
FK: Whole Body Vibration Flexed Knees Group
LK: Whole Body Vibration Locked Knees Group
CON: Control Group
a Body mass index: an indicator of body fat calculated by weight (kg)/height
2 (m). Normal values range from 18.5 - 24.9 kg/m
2.
Values ≥25 kg/m
2 are considered overweight, and ≥30 kg/m
2 are considered obese.
b The Physical Activity Scale for the Elderly (PASE) was used to monitor habitual physical activity over the preceding seven days. A higher score reflects more
physical activity [51]
c measured by Peripheral Quantitative Computed Tomography ( pQCT)
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2, FK 2.4 cm
2, CON 2.2 cm
2 p
= 0.13; ES 0.28, 95% CI (-0.91, 1.48)) were observed
after WBV with LK compared to FK or CON exposures.
There were no other significant or clinically meaningful
changes observed in physical performance over the
three months (Table 4).
Discussion
This is the first randomised controlled trial (RCT), to
our knowledge, comparing different standing postures
during WBV exposure in older adults. As hypothesised,
three months of WBV exposure significantly improved
absolute and relative lower body muscle strength and
relative upper body strength and peak contraction velo-
city. The FK position was significantly better than LK
for upper body muscle velocity improvement as
hypothesised, but had no influence on muscle strength
changes. A large calculated ES value for upper body
contraction velocity adds support to the robustness of
our findings for this outcome. This study is also to our
knowledge, the first to report significant increases in
upper body strength and contraction velocities after
WBV. As expected, due to the pilot nature of this work
(n = 16), type II errors likely contributed to the lack of
significance for many of the other outcomes. The
remainder of ESs were negligible to low, and all of the
CIs included zero. Post-hoc power calculations of lower
limb (leg press) strength indicated that a total of 78 sub-
jects would be needed to demonstrate significance.
Chest press contraction velocity improved after WBV
exposure, with an increase of 15.2% observed when
standing in the FK position. Changes in contraction
v e l o c i t ym a yb et h ep r i m a r ym e c h a n i s mb yw h i c ht o
improve peak power in older adults [56]. Because mus-
cle power declines faster in older adults than strength
does [57] and is more closely related to physical perfor-
mance, functional independence and mobility than mus-
cle strength [58,59] this finding may be clinically
relevant. Muscle power has also been observed to
improve with low, moderate and high load, high velocity
power training [56]. Low load power training is most
similar to the low-loading conditions during WBV expo-
sure, although the frequency and number of contrac-
tions induced with the WBV would be far greater. Thus,
WBV may provide an alternative exercise modality for
those who cannot undertake power training. This,
Table 3 Baseline Participant Functional Performance
FK LK CON
Variable Total (n = 19) p-value
(n = 6) (n = 5) (n = 8)
Maximal Strength (N)
a -
- Leg Press 1339.9 ± 416.1 1308.0 ± 579.2 1252.4 ± 289.6 1418.5 ± 380.0 0.78
- Chest press 327.1 ± 149.8 313.0 ± 190.9 293.0 ± 134.9 354.8 ± 137.8 0.79
Relative Strength (kg/kg)
b-
- Leg Press 8.9 ± 1.6 8.9 ± 2.1 8.4 ± 1.4 9.3 ± 1.5 0.38
Peak Power (W) -
- Leg Press 652.3 ± 317.4 635.7 ± 438.3 637.6 ± 267.8 673.9 ± 282.6 0.97
- Chest Press 210.8 ± 108.4 191.3 ± 124.3 210.3 ± 69.4 225.6 ± 121.8 0.86
Peak Velocity (cm/s) -
- Leg Press 94.5 ± 19.3 86.8 ± 21.8 89.3 ± 1.0 103.4 ± 20.1 0.23
- Chest Press 126.5 ± 32.0 115.1 ± 30.7 137.9 ± 16.8 129.4 ± 38.7 0.54
Balance Index
c 98.8 ± 25.2 98.0 ± 20.0 106.348 ± 30.2 94.8 ± 27.8 0.74
5 Chair rise time (s) 10.1 ± 1.7 10.1 ± 1.8 10.1 ± 1.2 10.1 ± 2.0 1.0
Stair Climb Power (W)
d 461.8 ± 195.9 420.2 ± 213.1 415.3 ± 92.4 530.6 ± 236.9 0.52
Habitual Gait Velocity (m/s)
e 1.4 ± 0.2 1.3 ± 0.2 1.4 ± 0.2 1.3 ± 0.2 0.80
Maximal Gait Velocity (m/s)
e 2.2 ± 0.4 2.2 ± 0.4 2.1 ± 0.3 2.3 ± 0.4 0.58
Six Minute Walk (m) 619.4 ± 77.0 612.5 ± 110.0 595.4 ± 50.3 639.5 ± 65.1 0.61
All data presented as mean ± SD
Continuous variables analysed by ANOVA for normally distributed data
FK: Whole Body Vibration Flexed Knees Group
LK: Whole Body Vibration Locked Knees Group
CON: Control Group
a Maximal Strength was measured via 1 repetition maximum (1RM) testing in Newtons
b Relative Strength (kg/kg): (leg press strength (kg)/leg Fat Free Mass (kg)) measured by Dual X-Ray absorptiometry (DXA)
c Balance Index : (Sum of 12 sway measures + (180 - sum of 6 time measures) [49]
dStair Climb power (W): (Body Mass (kg) × vertical height of the staircase (m)) × 9.8/time (s)
e Gait velocity (average of 2 trials for habitual gait; maximal of 2 trials for maximal gait) measured over 2 m using an Ultratimer
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Page 8 of 13however, remains to be shown in future studies directly
comparing the physiological and clinical benefits of
power training vs. WBV, as no changes in muscle power
itself were observed in this study. It is likely that greater
improvements in muscle strength and/or velocity would
have been necessary to improve power output itself [60].
Muscle Strength
We observed significant differences in strength between
WBV and CON participants after three months, as
hypothesised. Despite statistical significance of the
increase in upper and lower body strength, the increases
are smaller than those typically observed following resis-
tance training in older adults [61]. Thus, the clinical
relevance and long-term benefits of strength changes
associated with WBV remain to be demonstrated.
Although we anticipated more robust changes in lower
body muscle function than upper body changes, due to
dissipation of vibration transmission over the length of
the body, this was true for muscle strength, but not con-
traction velocity. With no previous literature available
for comparison, these findings require further investiga-
tion through more robust studies, testing specifically for
the influence of knee position during WBV exposure on
upper and lower body muscle strength, power and con-
traction velocity.
Effect of Standing Posture on Muscle Adaptations
The greater increase in upper body muscle velocity in
the FK group over LK vs. CON supports our hypothesis
that standing with flexed knees during WBV exposure
facilitates adaptations in muscle. A similar vibration pro-
tocol was applied to investigate the transmissibility of
vibration through to different areas of the skeleton
Table 4 Between Group Changes From Baseline to 3 Months
Variable FK LK CON
p value Power
(n = 5) (n = 4) (n = 7)
Muscle Function and Mass
Maximal Strength (N)
a -
- Leg Press 93.03 (-4.3, 190.37) 202.32 (85.05, 319.59) 9.59 (-75.11, 94.30) 0.05* 0.59
- Chest press -2.46 (-50.38, 45.50) -3.72 (-98.91, 61.46) -12.51 (-56.40, 31.38) 0.93 0.06
Peak Power (W)
b -
- Leg Press 41.19 (-23.99, 106.37) 95.73 (22.12, 169.35) 119.19 (65.74, 172.63) 0.18 0.29
- Chest Press 11.34 (-13.02, 35.70) -0.09 (-47.04,47.02) 3.08 (-26.43, 32.58) 0.81 0.07
Peak Velocity (cm/s)
b-
- Leg Press -10.36 (-140.71, 119.99) 43.02 (-104.10, 190.15) 59.53 (-48.98, 168.05) 0.68 0.10
- Chest Press 15.48 (3.59, 27.37) -3.12 (-24.81, 18.58) 0.33 (-13.42, 14.08) 0.15 0.34
Skeletal Muscle Cross - Sectional Area measured at 66% site (cm
2)
b,c
- Mid-Calf 2.43 (-2.02, 6.94) 3.65 (-1.91, 9.20) -2.2 (-6.043, 1.65) 0.13 0.39
- Mid-Forearm -0.24 (-1.52, 1.04) -0.48 (-2.18, 1.23) 0.03 (-1.16, 1.22) 0.87 0.07
Functional Performance
Balance Index
d 0.73 (-10.83, 12.28) -7.19 (-20.42, 6.04) -11.35 (-22.24, -0.47) 0.28 0.24
5 Chair Rise Time (s) -0.65 (-2.07, 0.78) -1.29 (-2.87, 0.30) -1.29 (-2.59, 0.01) 0.73 0.09
Stair Climb Power (W)
e 84.10 (-28.02, 196.30) 63.68 (-55.17, 182.54) 42.75 (-63.86, 149.35) 0.86 0.07
Habitual Gait Velocity (m/s)
f 0.40 (-0.02, 0.81) 0.04 (-0.04, 0.50) 0.07 (-0.30, 0.45) 0.38 0.19
Maximal Gait Velocity (m/s)
f 0.09 (-0.11, 0.30) 0.01 (-0.22, 0.24) 0.09 (-0.1, 0.28) 0.81 0.75
Six Minute Walk Distance (m) 36.15 (3.18, 69.12) 22.92 (-14.27, 60.11) 31.58 (1.01, 62.15) 0.84 0.07
Data presented as Estimated Marginal Means, adjusted mean difference (95% Confidence Intervals) after Analysis of Covariance (ANCOVA) testing using baseline
values as the covariate
All data presented as mean ± SD
WBV FK: Whole Body Vibration Flexed Knees Group
WBV LK: Whole Body Vibration Locked Knees Group
CON: Control Group
* Indicates a significant difference between the three groups (p ≤ 0.05)
a Maximal strength was measured via 1 repetition maximum (1RM) testing in Newtons
b Estimated Marginal Means after Analysis of Covariance (ANCOVA) testing using baseline values and month of baseline pQCT scan as covariates
c Measured by Peripheral Quantitative Computed Tomography (pQCT)
d Balance index : (Sum of 12 sway measures + (180 - sum of 6 time measures) [49]
e Stair climb power (W): Body Mass (kg) × vertical height of the staircase (m) × 9.8/time (s)
f Gait velocity (average of 2 trials for habitual gait; maximal of 2 trials for maximal gait) measured over 2 m using an Ultratimer
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Page 9 of 13when subjects adopted various knee positions [44]. The
findings suggest that a flexed knee position may dampen
vibrations to the skeleton. Similarly, our hypothesis pro-
posed that this damping could actually facilitate the
vibration adaptation muscle, resulting in better muscle
function or morphology gains. Our results, however,
provide inconsistent support for this hypothesis. Lower
limb (leg press) strength improved significantly in both
absolute and relative terms after three months of WBV
exposure, however a greater increase was observed in
the LK group than the FK group.
There are several explanations for these unexpected
findings. Although all training was fully supervised and
specific directions for standing position was given by the
instructor, subjects could have unconsciously performed
an isometric contraction of the quadriceps intermittently
to stabilise the LK position during the WBV exposure.
This may have inadvertently made the LK position more
Figure 3 Percentage change in chest press peak velocity following whole body vibration training. Data presented as Estimated Marginal
Means, adjusted mean difference ± standard deviation after analysis of covariance (ANCOVA) testing using month of baseline assessment and
baseline values as the covariates. FK = flexed knees group, LK = locked knees group, CON = control group * significant between group change.
Figure 4 Percentage change in leg press strength following whole body vibration training. Data presented as Estimated Marginal Means,
adjusted mean difference ± standard deviation after analysis of covariance (ANCOVA) testing using month of baseline assessment and baseline
values as the covariates. FK = flexed knees group, LK = locked knees group, CON = control group * significant between group change.
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Page 10 of 13effective for muscle than the FK position, not due to
dampening of vibrations, rather as a result of unin-
tended concomitant isometric exercise. Many studies
show that isometric contractions increase muscle
strength, often to the same extent as dynamic contrac-
tions [62] which could explain the greater improvement
with the LK position compared to FK for leg strength
outcomes in our study. Such isometric contractions of
leg muscles would not have influenced upper body
strength, and this is supported by the similar strength
changes observed for the LK and FK groups in the
upper body. Further studies using electromyography
(EMG) analysis to measure muscle activation of the
upper and lower body during WBV, as well as acceler-
ometer recordings over various body segments to mea-
sure vibration transmission with both locked knees and
flexed knees posture may assist in determining the effect
of stance on muscle contraction and transmission, and
thereby refine the WBV prescription to include optimal
stance to facilitate vibration to muscle.
Muscle Morphology
While there were no significant improvements in muscle
cross sectional area of the upper or lower limbs, the FK
group showed potentially clinically relevant muscle
increases at the mid calf compared to the CON group.
The lack of significance is likely partially due to a type
II error given that our pilot study was inadequately pow-
ered for the ES of 0.28 noted in this secondary outcome.
Calf muscle strength and size has been associated with
gait and balance in older adults [63], and is therefore a
potentially important clinical outcome. There are no
other studies to our knowledge that have examined
changes in muscle cross sectional area using pQCT after
WBV exposure in older adults. The need for more
robust, long term and sufficiently powered studies is
emphasised by our findings.
There are several limitations in our study design. The
study was underpowered for the secondary outcomes.
Three months of WBV exposure may not have been
sufficient to stimulate any musculoskeletal adaptations,
particularly in muscle morphology. A four group fully-
factorial design would be the optimal design to test the
interaction of vibration and knee position on study out-
comes. A lack of familiarisation tests prior to baseline
assessment, as well as different assessors for baseline
and three month testing may have led to results con-
founded by learning effects and differences due to asses-
sor encouragement and testing experience. We have
only tested one vibration magnitude (0.3g), the dose
recommended by Rubin et al [44] to be beneficial to
bone and not destructive to osteoblasts. It is possible
that a different vibration magnitude is needed for opti-
mal muscle adaptations, and in fact, many other studies
have used higher g forces with success for such out-
comes [2,32,33]. Specific dose-response studies varying
vibration magnitude and total dose are required to
refine this aspect of the prescription.
Conclusions
The results of this pilot RCT have provided some sup-
port for the efficacy of WBV exposure as a potential
Figure 5 Percentage change in chest press strength following whole body vibration training. Data presented as Estimated Marginal
Means, adjusted mean difference ± standard deviation after analysis of covariance (ANCOVA) testing using month of baseline assessment and
baseline values as the covariates. FK = flexed knees group, LK = locked knees group, CON = control group * significant between group change.
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Page 11 of 13alternative to existing exercise modalities in increasing
upper and lower body muscle strength and upper body
contraction velocity in healthy older adults. With the
aging population leading to a rise in the incidence of
musculoskeletal disorders, the efficacy of WBV as a
treatment modality warrants further investigation, parti-
cularly in mobility-limited cohorts, to assess whether
WBV exposure can alleviate muscle wasting due to dis-
ease and inactivity. Following the novel and significant
changes to upper body muscle function reported, future
WBV research should include additional measures of
upper body muscle function and morphology to deter-
mine the accuracy and reproducibility of our findings.
Most importantly, future research must also establish
whether improvements from WBV are retained once the
vibration stimulus is withdrawn, and whether any mean-
ingful clinical benefits ensue.
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